Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER studyPierFranco Conte, Valentina Guarneri, Giancarlo Bisagni et al.|Annals of Oncology|2018Cited by 157